ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Antibe Therapeutics Inc (CE)

Antibe Therapeutics Inc (CE) (ATBPF)

0,2156
0,00
(0,00%)
Fermé 31 Janvier 10:00PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
0,2156
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,1113 Plage de 52 semaines 0,7904
Clôture Veille
0,2156
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

ATBPF Dernières nouvelles

Antibe Therapeutics Reports Q3 2015 Interim Financial and Operating Results and Director Resignation

Antibe Therapeutics Inc. (“Antibe”) (TSXV:ATE, OTCQX:ATBPF) filed its financial and operating results today for the fiscal quarter ended December 31, 2014. The Corporation’s unaudited Q3...

Antibe Therapeutics Provides Update on Its Acute Pain Drug ATB-352

Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV: ATE; OTCQX: ATBPF) is pleased to report results from animal proof-of-concept studies on ATB-352, which is the second drug in...

Antibe Therapeutics Completes Single Ascending Dose Portion of ATB-346 Phase I Program

Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE; OTCQX:ATBPF) is pleased to report that the pre-scheduled single ascending dose portion of its Phase I program has been...

Antibe Therapeutics Reports on Results of AGM Voting

Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE; OTCQX:ATBPF) is pleased to report the results of the voting on the matters submitted to the annual meeting of shareholders...

OTC Markets Group Welcomes Antibe Therapeutics to OTCQX®

OTC Markets Group Welcomes Antibe Therapeutics to OTCQX® PR Newswire NEW YORK, Sept. 15, 2014 NEW YORK, Sept. 15, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
26000.21560.21560.215600CS
52-0.5454-71.66885676740.7610.79040.1113319590.39198279CS
156-0.29067-57.41402808780.506270.88550.1113128880.46465047CS
260-0.1782-45.2513966480.39385.880.1113795410.6613346CS

ATBPF - Frequently Asked Questions (FAQ)

What is the current Antibe Therapeutics (CE) share price?
The current share price of Antibe Therapeutics (CE) is US$ 0,2156
What is the 1 year trading range for Antibe Therapeutics (CE) share price?
Antibe Therapeutics (CE) has traded in the range of US$ 0,1113 to US$ 0,7904 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RLLVFRelevium Technologies Inc (CE)
US$ 0,008
(799 900,00%)
8k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799 900,00%)
318
CASGCanadian Aerospace Group International (CE)
US$ 0,001
(99 900,00%)
1 000
BLIBQBB Liquidating Inc (CE)
US$ 0,001
(99 900,00%)
204
NTBLQNotable Labs Ltd (CE)
US$ 0,0199
(19 800,00%)
21,97k
ISUNQiSun Inc (CE)
US$ 0,000001
(-99,90%)
200
JFTHJapan Food Tech Holdings Inc (CE)
US$ 0,000001
(-99,50%)
453
JAMNJammin Java Corp (PK)
US$ 0,000001
(-99,00%)
156,25k
INTKIndustrial Nanotech Inc (PK)
US$ 0,000001
(-99,00%)
28,16k
SGMDSugarmade Inc (CE)
US$ 0,000001
(-99,00%)
35,78k
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0002
(100,00%)
228,93M
GMPRGourmet Provisions International Corporation (PK)
US$ 0,000001
(-99,00%)
164,82M
HMBLHUMBL Inc (PK)
US$ 0,0007
(16,67%)
154,01M
THBDThird Bench Inc (PK)
US$ 0,0001
(-33,33%)
133,1M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0028
(-6,67%)
110,11M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock